Premium
Clinical practice guidelines for IgG4‐related sclerosing cholangitis
Author(s) -
Kamisawa Terumi,
Nakazawa Takahiro,
Tazuma Susumu,
Zen Yoh,
Tanaka Atsushi,
Ohara Hirotaka,
Muraki Takashi,
Inui Kazuo,
Inoue Dai,
Nishino Takayoshi,
Naitoh Itaru,
Itoi Takao,
Notohara Kenji,
Kanno Atsushi,
Kubota Kensuke,
Hirano Kenji,
Isayama Hiroyuki,
Shimizu Kyoko,
Tsuyuguchi Toshio,
Shimosegawa Tooru,
Kawa Shigeyuki,
Chiba Tsutomu,
Okazaki Kazuichi,
Takikawa Hajime,
Kimura Wataru,
Unno Michiaki,
Yoshida Masahiro
Publication year - 2019
Publication title -
journal of hepato‐biliary‐pancreatic sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.63
H-Index - 60
eISSN - 1868-6982
pISSN - 1868-6974
DOI - 10.1002/jhbp.596
Subject(s) - medicine , guideline , primary sclerosing cholangitis , delphi method , autoimmune pancreatitis , clinical practice , differential diagnosis , general surgery , pancreatitis , disease , family medicine , pathology , computer science , artificial intelligence
IgG4‐related sclerosing cholangitis (IgG4‐ SC ) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4‐related disease. Although clinical diagnostic criteria of IgG4‐ SC were established in 2012, differential diagnosis from primary sclerosing cholangitis and cholangiocarcinoma is sometimes difficult. Furthermore, no practical guidelines for IgG4‐ SC are available. Because the evidence level of most articles retrieved through searching the PubMed, Cochrane Library, and Igaku Chuo Zasshi databases was below C based on the systematic review evaluation system of clinical practice guidelines MINDS 2014, we developed consensus guidelines using the modified Delphi approach. Three committees (a guideline creating committee, an expert panelist committee for rating statements according to the modified Delphi method, and an evaluating committee) were organized. Eighteen clinical questions ( CQ s) with clinical statements were developed regarding diagnosis (14 CQ s) and treatment (4 CQ s). Recommendation levels for clinical statements were set using the modified Delphi approach. The guidelines explain methods for accurate diagnosis, and safe and appropriate treatment of IgG4‐ SC .